EPO and myelofibrosis: Erythrocyte lifespans decrease in response to high PTH levels[24]; and high PTH levels inhibit hematopoietic stem cell activity, particularly that of erythroid burst-forming units, as well as inducing myelofibrosis and contributing to erythropoietin resistance[24,25].